KOD – kodiak sciences inc (US:NASDAQ)
Stock Stats
News
Kodiak Sciences: Shares Up On Positive Eye Disease Data - But I Remain On Sidelines [Seeking Alpha]
Kodiak Sciences (KOD) had its price target raised by UBS Group AG from $50.00 to $80.00. They now have a "buy" rating on the stock.
Kodiak Sciences (KOD) had its "buy" rating reaffirmed by HC Wainwright. They now have a $58.00 price target on the stock, up from $38.00.
Kodiak Sciences (KOD) CLimbs 75% on Stellar Clinical Results [Yahoo! Finance]
Kodiak Sciences Announces Positive Topline Results in GLOW2, the Second Phase 3 Study in Diabetic Retinopathy, Demonstrating Superiority of Zenkuda™ (tarcocimab tedromer) Over Sham [Yahoo! Finance]
Form 4 Kodiak Sciences Inc. For: Mar 25 Filed by: PERLROTH VICTOR
Form 8-K Kodiak Sciences Inc. For: Mar 26
Form SCHEDULE 13G/A Kodiak Sciences Inc. Filed by: Point72 Asset Management, L.P.
Form 5 Kodiak Sciences Inc. For: Dec 31 Filed by: PERLROTH VICTOR
Form SCHEDULE 13G/A Kodiak Sciences Inc. Filed by: PERLROTH VICTOR
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.